The proposition was approved by shareholders Monday, according to a memo posted on the Bucharest bourse.
Ropharma is indirectly owned by businessman Mihai Miron, through two offshores, which hold a 44.9% stake between them. Other shareholders include Arrow Pharmaceuticals with 31.31% and privatization authority AVAS with 0.33%.
Ropharma has a share capital of RON29.1 million, divided into 291 million shares with a face value of RON0.1.
Company shares were last traded Friday, at RON0.78, down 2.5% on the day. (EUR1=RON4.2429)